HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel Einhorn Selected Research

Daniel Einhorn Research Topics

Disease

9Type 2 Diabetes Mellitus (MODY)
06/2020 - 09/2004
6Hypoglycemia (Reactive Hypoglycemia)
01/2022 - 09/2004
4Cardiovascular Diseases (Cardiovascular Disease)
10/2020 - 09/2004
4Type 1 Diabetes Mellitus (Autoimmune Diabetes)
06/2020 - 09/2004
3Heart Failure
10/2017 - 04/2010
3Myocardial Infarction
10/2017 - 04/2010
2Non-alcoholic Fatty Liver Disease
01/2022 - 08/2019
2Hypertension (High Blood Pressure)
01/2022 - 08/2019
2Insulin Resistance
06/2020 - 09/2004
2Diabetes Complications
06/2020 - 09/2009
2Chronic Renal Insufficiency
08/2019 - 11/2015
2Unstable Angina
04/2010 - 04/2010
2Glucose Intolerance
04/2010 - 04/2010
2Stroke (Strokes)
04/2010 - 04/2010
1Prediabetic State (Prediabetes)
01/2022
1Cognitive Dysfunction
01/2022
1Pain (Aches)
06/2020
1Obesity
06/2020
1Hyperglycemia
08/2019
1Kidney Diseases (Kidney Disease)
08/2019
1Chronic Kidney Failure (Chronic Renal Failure)
08/2019
1Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2019
1Fournier Gangrene
01/2019
1Endocrine System Diseases (Endocrine Diseases)
11/2017
1Diabetes Mellitus
08/2017
1Coronary Artery Disease (Coronary Atherosclerosis)
08/2017
1Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
06/2016
1Sleep Apnea Syndromes (Sleep Apnea)
06/2007
1Apnea
06/2007

Drug/Important Bio-Agent (IBA)

4Insulin (Novolin)FDA Link
06/2020 - 09/2004
3Hypoglycemic Agents (Hypoglycemics)IBA
01/2022 - 01/2012
2LipidsIBA
01/2022 - 10/2020
2InsulinsIBA
06/2020 - 09/2004
2Sodium-Glucose Transport ProteinsIBA
08/2019 - 01/2019
2Pioglitazone (Actos)FDA Link
11/2016 - 09/2004
2Glucose (Dextrose)FDA LinkGeneric
08/2015 - 01/2012
2Hemoglobins (Hemoglobin)IBA
08/2015 - 09/2009
2Nateglinide (Starlix)FDA LinkGeneric
04/2010 - 04/2010
2Valsartan (Vals)FDA Link
04/2010 - 04/2010
1Nonesterified Fatty Acids (NEFA)IBA
08/2019
1Triglycerides (Triacylglycerol)IBA
08/2019
1CytokinesIBA
08/2019
1Biosimilar PharmaceuticalsIBA
11/2017
1LiraglutideFDA Link
10/2017
1Glucagon-Like Peptide 1 (GLP 1)IBA
10/2017
1empagliflozinIBA
10/2017
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
08/2017
1Angiotensin Receptor AntagonistsIBA
08/2017
1Sodium-Glucose Transporter 2 InhibitorsIBA
06/2016
1SodiumIBA
06/2016
1Pharmaceutical PreparationsIBA
11/2015
1CreatinineIBA
11/2015
1Cystatin CIBA
11/2015
1insulin degludecIBA
08/2015
1Insulin Glargine (Lantus)FDA Link
08/2015
1SecretagoguesIBA
04/2010
1Short-Acting InsulinIBA
04/2010
1Insulin Lispro (Humalog)FDA Link
09/2004
1Blood Glucose (Blood Sugar)IBA
09/2004
1Rosiglitazone (Avandia)FDA Link
09/2004
1ThiazolidinedionesIBA
09/2004

Therapy/Procedure

6Therapeutics
01/2022 - 09/2004
6Glycemic Control
06/2020 - 05/2007
1Drug Therapy (Chemotherapy)
06/2020
1Injections
06/2020
1Physical Therapy Modalities (Physical Therapy Technique)
06/2020
1Continuity of Patient Care
08/2017
1Cannula
06/2007
1Pressure Transducers (Pressure Transducer)
06/2007